Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant By Guilherme GuainJune 30, 2022
Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial. By Guilherme GuainJune 30, 2022
S-Adenosyl-Methionine improves depression in patients with Parkinson’s disease in an open-label clinical trial By Guilherme GuainJune 30, 2022
S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response By Guilherme GuainJune 30, 2022
Oral Administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 Improves the Mild-To-Moderate Symptoms of Depression: A Randomized, Double-Blind, Placebo-Controlled Study By Guilherme GuainJune 30, 2022
Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial By Guilherme GuainJune 30, 2022
Petal and Stigma of Crocus sativus L. in the Treatment of Depression: A Pilot Double – blind Randomized Trial By Guilherme GuainJune 30, 2022
A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression By Guilherme GuainJune 30, 2022
